Afficher la notice abrégée

Adherence to treatment guidelines in clinical practice for using electroconvulsive therapy in major depressive episode

dc.rights.licenseopenen_US
dc.contributor.authorSAMALIN, L.
dc.contributor.authorYRONDI, A.
dc.contributor.authorCHARPEAUD, T.
dc.contributor.authorGENTY, J.B.
dc.contributor.authorBLANC, O.
dc.contributor.authorSAUVAGET, A.
dc.contributor.authorSTEPHAN, F.
dc.contributor.authorWALTER, M.
dc.contributor.authorBENNABI, D.
dc.contributor.authorBULTEAU, Samuel
dc.contributor.authorHAESEBAERT, F.
dc.contributor.authorD'AMATO, T.
dc.contributor.authorPOULET, E.
dc.contributor.authorHOLTZMANN, J.
dc.contributor.authorRICHIERI, R.M.
dc.contributor.authorATTAL, J.
dc.contributor.authorNIETO, I.
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorEL-HAGE, Wissam
dc.contributor.authorBELLIVIER, F.
dc.contributor.authorSCHMITT, L.
dc.contributor.authorLANCON, C.
dc.contributor.authorBOUGEROL, T.
dc.contributor.authorLEBOYER, M.
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorAOUIZERATE, Bruno
IDREF: 069471851
dc.contributor.authorHAFFEN, E.
dc.contributor.authorCOURTET, P
dc.contributor.authorLLORCA, P.M.
dc.date.accessioned2023-05-24T09:35:35Z
dc.date.available2023-05-24T09:35:35Z
dc.date.issued2020-03-01
dc.identifier.issn0165-0327en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/182294
dc.description.abstractEnBackground: ECT is the most effective treatment of major depressive episode (MDE) but remains a neglected treatment. The French Society for Biological Psychiatry and Neuropsychopharmacology aimed to determine whether prescribing practice of ECT followed guidelines recommendations. Methods: This multicenter, retrospective study included adult patients with major depressive disorder (MDD) or bipolar disorder (BD), who have been treated with ECT for MDE. Duration of MDE and number of lines of treatment received before ECT were collected. The reasons for using ECT, specifically first-line indications (suicidality, urgency, presence of catatonic and psychotic features, previous ECT response, patient preference) were recorded. Statistical comparisons between groups used standard statistical tests. Results: Seven hundred and forty-five individuals were included. The mean duration of MDE before ECT was 10.1 months and the mean number of lines of treatment before ECT was 3.4. It was significantly longer for MDD single episode than recurrent MDD and BD. The presence of first-line indications for using ECT was significantly associated to shorter duration of MDE (9.1 vs 13.1 months, p<0.001) and lower number of lines of treatment before ECT (3.3 vs 4.1, p<0.001). Limitations: This is a retrospective study and not all facilities practicing ECT participated that could limit the extrapolation of the results. Conclusion: : Compared to guidelines, ECT was not used as first-line strategy in clinical practice. The presence of first-line indications seemed to reduce the delay before ECT initiation. The improvements of knowledge and access of ECT are needed to decrease the gap between guidelines and clinical practice.
dc.language.isoENen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc/
dc.title.enAdherence to treatment guidelines in clinical practice for using electroconvulsive therapy in major depressive episode
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.jad.2020.01.004en_US
dc.subject.halSciences du Vivant [q-bio]en_US
dc.subject.halSciences du Vivant [q-bio]/Génétiqueen_US
dc.subject.halSciences du Vivant [q-bio]/Génétique/Génétique animaleen_US
dc.identifier.pubmed32056767en_US
bordeaux.journalJournal of Affective Disordersen_US
bordeaux.page318-323en_US
bordeaux.volume264en_US
bordeaux.hal.laboratoriesNutriNeuro (Laboratoire de Nutrition et Neurobiologie Intégrée) - UMR 1286en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINRAEen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcehal
hal.identifierhal-02622430
hal.version1
hal.exportfalse
workflow.import.sourcehal
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=Journal%20of%20Affective%20Disorders&amp;rft.date=2020-03-01&amp;rft.volume=264&amp;rft.spage=318-323&amp;rft.epage=318-323&amp;rft.eissn=0165-0327&amp;rft.issn=0165-0327&amp;rft.au=SAMALIN,%20L.&amp;YRONDI,%20A.&amp;CHARPEAUD,%20T.&amp;GENTY,%20J.B.&amp;BLANC,%20O.&amp;rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Nom:
NutriNeuro_JAD_2020_Samalin.pdf
Taille:
636.7Ko
Format:
PDF
Voir/Ouvrir

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée